Finally, we aimed to assess if MSA patients with early onset of sleep disorders showed a higher level of cerebrospinal fluid (CSF) neurofilament light chain (NfL), a reliable biomarker of disease severity in MSA [13]. The gene discussed is NEFL; the disease is multiple system atrophy.